Status:
COMPLETED
Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan
Lead Sponsor:
Foundation for Innovative New Diagnostics, Switzerland
Conditions:
Cutaneous Leishmaniases
Eligibility:
All Genders
2+ years
Brief Summary
New point-of-care (POC) tests are needed and assessing the performance of these tests for cutaneous leishmaniasis (CL) in Afghanistan may help increasing the number of CL patients with access to accur...
Detailed Description
The investigators enrolled 274 CL suspects in the study to determine the diagnostic performance of LoopampTM Leishmania Detection Kit and CL DetectTM Rapid Test for CL diagnosis in Afghanistan. The st...
Eligibility Criteria
Inclusion
- Clinical signs compatible with cutaneous leishmaniasis
- Age ≥ than two years old.
- Informed consent obtained and documented.
- Clinical samples can be obtained.
Exclusion
- Age less than two years old.
- Failure to obtain and document informed consent.
- Cutaneous leishmaniasis suspects from whom, for any reason, the required clinical samples needed for the study cannot be obtained.
- Patients already receiving CL treatment at the time of enrolment.
Key Trial Info
Start Date :
April 16 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 18 2016
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT03435419
Start Date
April 16 2016
End Date
July 18 2016
Last Update
February 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.